Skip to main content

Table 3 Characteristics of the femoropopliteal lesions in both PCD and POBA groups

From: Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study

  POBA (n = 380) PCD (n = 320) p-value
Mean Lesion Length (mm) 111 + −89 135 + −91 p < 0.001
Occlusion 40.2% (n = 177) 50% (n = 199) p = 0.005
De Novo Lesion 100% (n=) 100% (n=) N/A
Reccurent lesion 0% (n = 0) 0% (n = 0) N/A
Prior Femoropopliteal Bypass 0% (n = 0) 0% (n = 0) N/A
Bilateral Treatment 16.3% (n = 62) 24.3% (n = 78) p < 0.01